Clinical Trial Update: A Survey of Lanadelumab in Participants With Hereditary Angioedema

View source ↗

Summary

A clinical trial update describing a survey of lanadelumab in participants with hereditary angioedema; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Takhzyro (lanadelumab)

Snippet

Sponsor: Takeda | Conditions: Hereditary Angioedema (HAE) | Status: ACTIVE_NOT_RECRUITING